Benzinga | Aug 12, 2021 05:27PM EDT

Aprea Therapeutics Q2 EPS $(0.48) Up From $(0.78) YoY

Aprea Therapeutics (NASDAQ:APRE) reported quarterly losses of $(0.48) per share. This is a 38.46 percent increase over losses of $(0.78) per share from the same period last year.